Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PLAU | P00749 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8302538 | 0.98 | GPR35 (0.55) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL782111 | 0.98 | GPR35 (0.55) | GPR35TSHRCTSDALDH1A1TDP1 | |
| Aziridine SCHEMBL3049817 | 0.92 | GPR35 (0.49) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL782562 | 0.91 | GPR35 (0.47) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL19127226 | 0.91 | GPR35 (0.47) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL5792626 | 0.88 | TSHR (0.48) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL30893562 | 0.85 | TSHR (0.68) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL3671 | 0.85 | TSHR (0.68) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL7417028 | 0.85 | GPR35 (0.60) | GPR35TSHRCTSDALDH1A1TDP1 | |
| SCHEMBL7263414 | 0.85 | GPR35 (0.60) | GPR35TSHRCTSDALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 653 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727950-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS | GlaxoSmithKline Intellectual Property Development Ltd (GB) | 2026-04-22 | — | — | EP | claimed |
| US-20260048047-A1 | SMALL-MOLECULE ACTIVATORS OF MYCOBACTERIUM TUBERCULOSIS ADENYLYL CYCLASE | SCRIPPS RESEARCH INST (US) | 2026-02-19 | — | — | US | claimed |
| EP-4602052-A1 | PROTEIN-BASED SIGNAL AMPLIFICATION | California Institute of Technology (US) | 2025-08-20 | — | — | EP | claimed |
| WO-2025096495-A1 | ARYL FLUOROSULFATE-BASED INHIBITORS AS NOVEL ANTITUBERCULAR AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250129084-A1 | Compounds | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2025-04-24 | — | — | US | claimed |
| EP-4486454-A1 | COMPOUNDS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2025-01-08 | — | — | EP | claimed |
| WO-2024256554-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2024-12-19 | — | — | WO | claimed |
| US-20240307385-A1 | NOVEL COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2024-09-19 | — | — | US | claimed |
| US-20240269340-A1 | MICROSPHERES WITH FLOW THROUGH VOIDS AS EMBOLIC AND DRUG DELIVERY AGENTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2024-08-15 | — | — | US | claimed |
| EP-4388114-A1 | CELL-TO-CELL DELIVERY OF RNA CIRCUITS | California Institute of Technology (US) | 2024-06-26 | — | — | EP | claimed |
| EP-0934068-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-08-11 | — | — | EP | claimed |
| WO-1998009630-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-03-12 | — | — | WO | claimed |
| CN-1151695-A | pharmaceutical composition containing benzamide | CENTAUR PHARMACEUTICALS INC (US) | 1997-06-11 | — | — | CN | claimed |
| EP-0091383-B1 | PROCESS FOR THE CATALYTIC REDUCTION OF NITRO-AROMATIC COMPOUNDS | Montedison S.p.A. (IT) | 1987-03-04 | — | — | EP | claimed |
| EP-0097592-B1 | PROCESS FOR CATALYTICALLY REDUCING NITROAROMATIC COMPOUNDS | Montedison S.p.A. (IT) | 1986-12-10 | — | — | EP | claimed |
| US-4535162-A | USING GROUP 8 METAL COORDINATION CATALYSTS | MONTEDISON S.P.A. (IT) | 1985-08-13 | — | — | US | claimed |
| EP-0097592-A2 | Process for catalytically reducing nitroaromatic compounds | Montedison S.p.A. (IT) | 1984-01-04 | — | — | EP | claimed |
| EP-0091383-A1 | Process for the catalytic reduction of nitro-aromatic compounds | Montedison S.p.A. (IT) | 1983-10-12 | — | — | EP | claimed |
| US-4260540-A | SPIN DYEING POLYACRYLONITRILE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-04-07 | — | — | US | claimed |
| US-4225489-A | Heterocyclic azo dyes and pigments containing 4-quinazolinone moieties | BAYER AKTIENGESELLSCHAFT (DE) | 1980-09-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129084-A1 | Compounds | CFTR, TBCA, TBCD | GPR35 2651/4885TSHR 3455/4885CTSD 755/4885 |
| US-20240307385-A1 | NOVEL COMPOUNDS | FNTB, SDHA, FDPS | GPR35 2177/4885TSHR 3330/4885CTSD 1624/4885 |
| US-20260048047-A1 | SMALL-MOLECULE ACTIVATORS OF MYCOBACTERIUM TUBERCULOSIS ADENYLYL CYCLASE | FNTB, PDE7A, TBL3 | GPR35 2067/4885TSHR 620/4885CTSD 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.